Guardant Net Debt from 2010 to 2025

GH Stock

USD 44.72 1.52 3.29%

Guardant Health's Net Debt is increasing with slightly volatile movements from year to year. Net Debt is estimated to finish at about 851 M this year. Net Debt is the total debt of Guardant Health minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2017-12-31

Previous Quarter

651 M

Current Value

810.5 M

Quarterly Volatility

509.4 M

Covid

Check Guardant Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Guardant Health's main balance sheet or income statement drivers, such as Tax Provision of 1.3 M, Net Interest Income of 53.7 M or Interest Income of 56.4 M, as well as many indicators such as Price To Sales Ratio of 4.82, Dividend Yield of 0.0022 or Days Sales Outstanding of 88.45. Guardant financial statements analysis is a perfect complement when working with Guardant Health Valuation or Volatility modules.

Check out the analysis of Guardant Health Correlation against competitors.

For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.

Latest Guardant Health's Net Debt Growth Pattern

Below is the plot of the Net Debt of Guardant Health over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Guardant Health's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Guardant Health's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Guardant Net Debt Regression Statistics

	Arithmetic Mean	222,198,788
	Geometric Mean	74,532,464
	Coefficient Of Variation	199.26
	Mean Deviation	358,632,931
	Median	(16,552,000)
	Standard Deviation	442,754,711
	Sample Variance	196031.7T
	Range	1.4B
	R-Value	0.69
	Mean Square Error	110318.6T
	R-Squared	0.47
	Significance	0
	Slope	64,077,510
	Total Sum of Squares	2940476T

Guardant Net Debt History

	2025	851 M
	2024	810.5 M
	2023	220.2 M
	2022	1.2 B
	2021	868.7 M
	2020	14.9 M
	2019	-110 M

Other Fundumenentals of Guardant Health

Net Debt To E B I T D A

Guardant Health Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Short Term Investments	Long Term Debt Total	Capital Surpluse	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Property Plant Equipment	Net Invested Capital	Net Working Capital	Intangible Assets	Deferred Long Term Liab	Capital Stock	Common Stock	Good Will
Total Assets		0.47	0.66	0.61	0.64	-0.7	0.63	0.9	0.89	0.75	0.88	0.95	0.88	-0.8	0.97	0.72	0.83	0.99	0.94	0.59	-0.26	-0.26	-0.26	-0.26
Total Stockholder Equity	0.47		0.92	-0.17	-0.25	0.25	-0.18	0.27	0.13	0.56	0.1	0.36	0.04	-0.41	0.48	-0.21	0.11	0.53	0.52	0.84	0.38	0.38	0.38	0.38
Net Tangible Assets	0.66	0.92		0.16	0.01	-0.05	0.02	0.53	0.38	0.71	0.39	0.61	0.27	-0.55	0.67	0.08	0.31	0.74	0.7	0.84	0.09	0.09	0.09	0.09
Current Deferred Revenue	0.61	-0.17	0.16		0.69	-0.92	0.66	0.77	0.79	0.39	0.83	0.72	0.69	-0.7	0.6	0.89	0.59	0.6	0.53	-0.06	-0.81	-0.81	-0.81	-0.81
Net Debt	0.64	-0.25	0.01	0.69		-0.79	0.77	0.68	0.81	0.54	0.8	0.66	0.82	-0.49	0.56	0.79	0.8	0.59	0.49	0.11	-0.51	-0.51	-0.51	-0.51
Retained Earnings	-0.7	0.25	-0.05	-0.92	-0.79		-0.81	-0.79	-0.86	-0.36	-0.9	-0.77	-0.86	0.64	-0.69	-0.99	-0.71	-0.65	-0.62	0.05	0.7	0.7	0.7	0.7
Accounts Payable	0.63	-0.18	0.02	0.66	0.77	-0.81		0.78	0.83	0.46	0.77	0.74	0.83	-0.61	0.63	0.84	0.67	0.58	0.55	0.08	-0.26	-0.26	-0.26	-0.26
Long Term Debt	0.9	0.27	0.53	0.77	0.68	-0.79	0.78		0.96	0.64	0.9	0.96	0.87	-0.85	0.86	0.81	0.84	0.89	0.78	0.39	-0.32	-0.32	-0.32	-0.32
Net Receivables	0.89	0.13	0.38	0.79	0.81	-0.86	0.83	0.96		0.6	0.94	0.95	0.95	-0.81	0.83	0.87	0.91	0.85	0.74	0.31	-0.38	-0.38	-0.38	-0.38
Short Term Investments	0.75	0.56	0.71	0.39	0.54	-0.36	0.46	0.64	0.6		0.6	0.73	0.54	-0.64	0.79	0.39	0.44	0.79	0.8	0.69	-0.15	-0.15	-0.15	-0.15
Long Term Debt Total	0.88	0.1	0.39	0.83	0.8	-0.9	0.77	0.9	0.94	0.6		0.91	0.9	-0.75	0.84	0.93	0.84	0.86	0.78	0.38	-0.55	-0.55	-0.55	-0.55
Capital Surpluse	0.95	0.36	0.61	0.72	0.66	-0.77	0.74	0.96	0.95	0.73	0.91		0.9	-0.82	0.94	0.79	0.81	0.94	0.89	0.48	-0.29	-0.29	-0.29	-0.29
Total Liab	0.88	0.04	0.27	0.69	0.82	-0.86	0.83	0.87	0.95	0.54	0.9	0.9		-0.67	0.84	0.87	0.91	0.82	0.77	0.25	-0.33	-0.33	-0.33	-0.33
Short Long Term Debt	-0.8	-0.41	-0.55	-0.7	-0.49	0.64	-0.61	-0.85	-0.81	-0.64	-0.75	-0.82	-0.67		-0.78	-0.65	-0.64	-0.79	-0.7	-0.41	0.32	0.32	0.32	0.32
Total Current Assets	0.97	0.48	0.67	0.6	0.56	-0.69	0.63	0.86	0.83	0.79	0.84	0.94	0.84	-0.78		0.71	0.69	0.97	0.99	0.56	-0.26	-0.26	-0.26	-0.26
Short Term Debt	0.72	-0.21	0.08	0.89	0.79	-0.99	0.84	0.81	0.87	0.39	0.93	0.79	0.87	-0.65	0.71		0.73	0.68	0.64	0.03	-0.67	-0.67	-0.67	-0.67
Property Plant Equipment	0.83	0.11	0.31	0.59	0.8	-0.71	0.67	0.84	0.91	0.44	0.84	0.81	0.91	-0.64	0.69	0.73		0.77	0.59	0.34	-0.24	-0.24	-0.24	-0.24
Net Invested Capital	0.99	0.53	0.74	0.6	0.59	-0.65	0.58	0.89	0.85	0.79	0.86	0.94	0.82	-0.79	0.97	0.68	0.77		0.95	0.64	-0.27	-0.27	-0.27	-0.27
Net Working Capital	0.94	0.52	0.7	0.53	0.49	-0.62	0.55	0.78	0.74	0.8	0.78	0.89	0.77	-0.7	0.99	0.64	0.59	0.95		0.59	-0.25	-0.25	-0.25	-0.25
Intangible Assets	0.59	0.84	0.84	-0.06	0.11	0.05	0.08	0.39	0.31	0.69	0.38	0.48	0.25	-0.41	0.56	0.03	0.34	0.64	0.59		0.23	0.23	0.23	0.23
Deferred Long Term Liab	-0.26	0.38	0.09	-0.81	-0.51	0.7	-0.26	-0.32	-0.38	-0.15	-0.55	-0.29	-0.33	0.32	-0.26	-0.67	-0.24	-0.27	-0.25	0.23		1.0	1.0	1.0
Capital Stock	-0.26	0.38	0.09	-0.81	-0.51	0.7	-0.26	-0.32	-0.38	-0.15	-0.55	-0.29	-0.33	0.32	-0.26	-0.67	-0.24	-0.27	-0.25	0.23	1.0		1.0	1.0
Common Stock	-0.26	0.38	0.09	-0.81	-0.51	0.7	-0.26	-0.32	-0.38	-0.15	-0.55	-0.29	-0.33	0.32	-0.26	-0.67	-0.24	-0.27	-0.25	0.23	1.0	1.0		1.0
Good Will	-0.26	0.38	0.09	-0.81	-0.51	0.7	-0.26	-0.32	-0.38	-0.15	-0.55	-0.29	-0.33	0.32	-0.26	-0.67	-0.24	-0.27	-0.25	0.23	1.0	1.0	1.0

Click cells to compare fundamentals

About Guardant Health Financial Statements

Investors use fundamental indicators, such as Guardant Health's Net Debt, to determine how well the company is positioned to perform in the future. Although Guardant Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

	Last Reported	Projected for Next Year
Net Debt	810.5 M	851 M
Net Debt To EBITDA	(2.08)	(1.97)

Currently Active Assets on Macroaxis

V	Visa Class A
S	SentinelOne
GM	General Motors
MSFT	Microsoft
F	Ford Motor

How To Invest In Guardant

Details

Is Guardant Stock a good investment?

Details

What is Guardant Health's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Guardant Health Correlation against competitors.

For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.

You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.56)

Revenue Per Share

6.021

Quarterly Revenue Growth

0.302

Return On Assets

(0.17)

Return On Equity

(45.84)

The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Guardant Net Debt from 2010 to 2025

Latest Guardant Health's Net Debt Growth Pattern

Guardant Net Debt Regression Statistics

Guardant Net Debt History

Other Fundumenentals of Guardant Health

Guardant Health Net Debt component correlations

About Guardant Health Financial Statements

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY